Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
about
mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosisEpilepsy related to developmental tumors and malformations of cortical developmentIncreased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.Contribution of tumor heterogeneity in a new animal model of CNS tumors.Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors.mTOR signaling in epilepsy: insights from malformations of cortical developmentTracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling.Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasiasEzrin mediates tethering of the gamma-aminobutyric acid transporter GAT1 to actin filaments via a C-terminal PDZ-interacting domain.Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.Long-term epilepsy-associated tumors.Surgery for focal cortical dysplasia in children using intraoperative mapping.Focal epilepsy associated with glioneuronal tumors.Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.Cell injury and premature neurodegeneration in focal malformations of cortical development.Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
P2860
Q24294367-2DDF6E87-D746-4614-A7BC-1D4B220BF8BFQ26829946-8FA5377C-7B4D-4832-90A3-8CA0A6C383A6Q27320582-FADCD166-67D6-4D4E-B611-AA7684178D9BQ30274622-84DC82BA-ABDF-4F5F-B0CA-988F9F467E6DQ33625447-9BA57B09-C0CF-4BCA-B2BC-202452FFB927Q33926192-BB91DFEF-1241-4963-B06A-B9AA75080EC5Q35245211-1D8EA94D-319A-4832-90AB-C9D19DD635A7Q36245097-16B73FD7-EB40-4641-A2AA-DA0D95E9BA30Q36326785-37BECF46-3852-467A-9B8A-07D3C1D80C46Q37263199-86A87224-C2A8-4DE4-AB06-BA390C930E4BQ37598955-23C406EC-14A1-4C09-977C-2D7E46067AC9Q38002123-C6ECF2E1-0832-4DDB-B938-3F33068ED84BQ38258184-421373A7-7331-4B55-AFE8-4EDEF9C585F1Q40579773-5FD7D358-83CC-41F7-A4E0-AD992F5680EBQ42181781-5A0FBADB-4414-41A1-A025-A1EAF6EE3B5EQ45213406-00C90E70-D47C-4B7E-8207-CAFC36BC6745Q53140986-BC52D712-BEDB-4D1B-A376-A19275E5343B
P2860
Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alterations of phosphatidylino ...... sociated glioneuronal lesions.
@en
type
label
Alterations of phosphatidylino ...... sociated glioneuronal lesions.
@en
prefLabel
Alterations of phosphatidylino ...... sociated glioneuronal lesions.
@en
P2093
P2860
P1433
P1476
Alterations of phosphatidylino ...... sociated glioneuronal lesions.
@en
P2093
Albert J Becker
Arend Koch
Christian E Elger
Horst Urbach
Johannes Schramm
Michael Majores
Volker Schick
P2860
P356
10.1111/J.1528-1167.2007.01291.X
P478
48 Suppl 5
P577
2007-01-01T00:00:00Z